STOCK TITAN

[Form 4] Scholar Rock Holding Corp Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Mo Qatanani, Chief Scientific Officer of Scholar Rock Holding Corp (SRRK), reported an insider sale on a Form 4. On 09/22/2025 the reporting person sold 3,353 shares of Scholar Rock common stock at a weighted average price of $30.6729 under a Rule 10b5-1 trading plan adopted March 31, 2025. After the sale the reporting person beneficially owns 108,964 shares represented by RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person and filed on 09/24/2025. The filing discloses the sale occurred in multiple transactions at prices ranging from $30.33 to $30.85, and the weighted average reflects those executions.

Mo Qatanani, Chief Scientific Officer di Scholar Rock Holding Corp (SRRK), ha riportato una vendita interna mediante un modulo Form 4. Il 22/09/2025 la persona che riporta ha venduto 3.353 azioni delle azioni ordinarie di Scholar Rock a un prezzo medio ponderato di $30.6729 secondo un piano di trading Rule 10b5-1 adottato il 31 marzo 2025. Dopo la vendita la persona che riporta detiene beneficialmente 108.964 azioni rappresentate da RSU. Il Form 4 è stato firmato da un procuratore in fact per conto della persona che riporta e presentato il 24/09/2025. La presentazione informa che la vendita è avvenuta in multiple transazioni a prezzi che vanno da $30.33 a $30.85, e la media ponderata riflette tali esecuzioni.
Mo Qatanani, Director Científico Jefe de Scholar Rock Holding Corp (SRRK), informó una venta de insiders mediante un Form 4. El 22/09/2025 la persona reportante vendió 3.353 acciones de las acciones ordinarias de Scholar Rock a un precio medio ponderado de $30.6729 bajo un plan de negociación Rule 10b5-1 adoptado el 31 de marzo de 2025. Después de la venta la persona reportante posee beneficiosamente 108.964 acciones representadas por RSU. El Form 4 fue firmado por un apoderado en nombre de la persona reportante y presentado el 24/09/2025. La presentación revela que la venta ocurrió en múltiples transacciones a precios que van desde $30.33 a $30.85, y la media ponderada refleja esas ejecuciones.
Mo Qatanani은 Scholar Rock Holding Corp (SRRK)의 최고 과학 책임자로, Form 4에 내부자 매매를 보고했습니다. 2025-09-22에 보고자(인)가 Scholar Rock의 보통주를 3,353주를 가중평균가 $30.6729로 매도했으며 Rule 10b5-1 거래계획에 따라 2025년 3월 31일에 채택되었습니다. 매도 후 보고자는 RSU로 표현된 108,964주를 유익하게 보유합니다. Form 4은 보고자를 대신하여 대리인에 의해 서명되었고 2025-09-24에 제출되었습니다. 제출서는 매도가 다수의 거래에서 이루어졌고 가격은 $30.33에서 $30.85 사이였으며 가중평균은 그 실행들을 반영한다고 공시합니다.
Mo Qatanani, Directeur Scientifique en Chef de Scholar Rock Holding Corp (SRRK), a signalé une vente d’initié sur un formulaire Form 4. Le 22/09/2025 la personne déclarant a vendu 3 353 actions des actions ordinaires de Scholar Rock à un prix moyen pondéré de $30.6729 dans le cadre d’un plan de trading Rule 10b5-1 adopté le 31 mars 2025. Après la vente, la personne déclarant détient de manière bénéficiaire 108 964 actions représentées par des RSU. Le Form 4 a été signé par un mandataire agissant au nom de la personne déclarant et déposé le 24/09/2025. Le dossier indique que la vente s’est déroulée en plusieurs transactions à des prix allant de $30.33 à $30.85, et la moyenne pondérée reflète ces exécutions.
Mo Qatanani, Chief Scientific Officer von Scholar Rock Holding Corp (SRRK), meldete einen Insider-Verkauf mit einem Formular Form 4. Am 22.09.2025 verkaufte die meldende Person 3.353 Aktien der Stammaktien von Scholar Rock zu einem gewichteten Durchschnittspreis von $30.6729 im Rahmen eines Rule 10b5-1 Handelsplans, der am 31. März 2025 beschlossen wurde. Nach dem Verkauf hält die meldende Person vorteilhaft 108.964 Aktien, vertreten durch RSU. Das Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet und am 24.09.2025 eingereicht. Die Einreichung offenbart, dass der Verkauf in mehreren Transaktionen zu Preisen von $30.33 bis $30.85 erfolgte, und der gewichtete Durchschnitt spiegelt diese Ausführungen wider.
Mo Qatanani، كبير مسؤولي العلم في شركة Scholar Rock Holding Corp (SRRK)، أبلغ عن بيع داخلي في نموذج 4. في 22/09/2025 باع الشخص المبلغ عنه 3,353 سهماً من أسهم Scholar Rock العادية بسعر متوسط مرجح قدره $30.6729 بموجب خطة تداول Rule 10b5-1 اعتمدت في 31 مارس 2025. بعد البيع، يملك الشخص المبلغ عنه فعلياً 108,964 سهماً ممثلة بواسطة RSUs. تم توقيع نموذج 4 من قبل وكيل نيابة عن الشخص المبلغ وتقدّم في 24/09/2025. تسجّل المقدمة أن البيع حدث في عدة معاملات بأسعار تتراوح بين $30.33 و$30.85، وأن المتوسط المرجّح يعكس تلك التنفيذات.
Mo Qatanani,Scholar Rock Holding Corp (SRRK) 的首席科学官,报告了 Form 4 的内部人出售。在 2025-09-22,报告人以加权平均价格 $30.6729 出售了 3,353 股 Scholar Rock 普通股,依据于 Rule 10b5-1 交易计划,该计划于 2025-03-31 通过。出售后,报告人以受益方式持有 108,964 股,由 RSU 表示。该 Form 4 由代表报告人的代理人签署并于 2025-09-24 提交。备案披露显示,出售分多笔交易进行,价格区间为 $30.33 到 $30.85,加权平均数反映了这些执行。
Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating pre-planned, non-discretionary trades
  • Clear disclosure of execution details: number of shares sold (3,353), weighted average price ($30.6729), and price range ($30.33–$30.85)
  • Filing appears timely and properly signed by an attorney-in-fact, supporting compliance
Negative
  • None.

Insights

TL;DR: A routine, pre-established Rule 10b5-1 sale by the CSO; transparent disclosure, no new material corporate developments.

The reported disposal of 3,353 shares was executed under a Rule 10b5-1 plan, which typically indicates pre-planned, non-discretionary trades and reduces the likelihood the sale signals new company-specific negative information. The filing clearly states the weighted average sale price and the execution price range, and it reports remaining beneficial ownership as 108,964 RSUs. From an investor perspective the disclosure is procedurally complete and timely; it documents insider liquidity but does not itself provide evidence of a change in company fundamentals.

TL;DR: Proper use of an attorney-in-fact and 10b5-1 plan shows governance and compliance adherence in insider trading disclosure.

The Form 4 shows appropriate governance controls: the trade was executed under a documented 10b5-1 plan adopted March 31, 2025, and the filing was signed by an authorized attorney-in-fact. The report includes necessary details: transaction date, number of shares sold, weighted average price, price range, and post-transaction beneficial ownership in RSUs. This level of disclosure supports regulatory compliance and transparency regarding insider transactions.

Mo Qatanani, Chief Scientific Officer di Scholar Rock Holding Corp (SRRK), ha riportato una vendita interna mediante un modulo Form 4. Il 22/09/2025 la persona che riporta ha venduto 3.353 azioni delle azioni ordinarie di Scholar Rock a un prezzo medio ponderato di $30.6729 secondo un piano di trading Rule 10b5-1 adottato il 31 marzo 2025. Dopo la vendita la persona che riporta detiene beneficialmente 108.964 azioni rappresentate da RSU. Il Form 4 è stato firmato da un procuratore in fact per conto della persona che riporta e presentato il 24/09/2025. La presentazione informa che la vendita è avvenuta in multiple transazioni a prezzi che vanno da $30.33 a $30.85, e la media ponderata riflette tali esecuzioni.
Mo Qatanani, Director Científico Jefe de Scholar Rock Holding Corp (SRRK), informó una venta de insiders mediante un Form 4. El 22/09/2025 la persona reportante vendió 3.353 acciones de las acciones ordinarias de Scholar Rock a un precio medio ponderado de $30.6729 bajo un plan de negociación Rule 10b5-1 adoptado el 31 de marzo de 2025. Después de la venta la persona reportante posee beneficiosamente 108.964 acciones representadas por RSU. El Form 4 fue firmado por un apoderado en nombre de la persona reportante y presentado el 24/09/2025. La presentación revela que la venta ocurrió en múltiples transacciones a precios que van desde $30.33 a $30.85, y la media ponderada refleja esas ejecuciones.
Mo Qatanani은 Scholar Rock Holding Corp (SRRK)의 최고 과학 책임자로, Form 4에 내부자 매매를 보고했습니다. 2025-09-22에 보고자(인)가 Scholar Rock의 보통주를 3,353주를 가중평균가 $30.6729로 매도했으며 Rule 10b5-1 거래계획에 따라 2025년 3월 31일에 채택되었습니다. 매도 후 보고자는 RSU로 표현된 108,964주를 유익하게 보유합니다. Form 4은 보고자를 대신하여 대리인에 의해 서명되었고 2025-09-24에 제출되었습니다. 제출서는 매도가 다수의 거래에서 이루어졌고 가격은 $30.33에서 $30.85 사이였으며 가중평균은 그 실행들을 반영한다고 공시합니다.
Mo Qatanani, Directeur Scientifique en Chef de Scholar Rock Holding Corp (SRRK), a signalé une vente d’initié sur un formulaire Form 4. Le 22/09/2025 la personne déclarant a vendu 3 353 actions des actions ordinaires de Scholar Rock à un prix moyen pondéré de $30.6729 dans le cadre d’un plan de trading Rule 10b5-1 adopté le 31 mars 2025. Après la vente, la personne déclarant détient de manière bénéficiaire 108 964 actions représentées par des RSU. Le Form 4 a été signé par un mandataire agissant au nom de la personne déclarant et déposé le 24/09/2025. Le dossier indique que la vente s’est déroulée en plusieurs transactions à des prix allant de $30.33 à $30.85, et la moyenne pondérée reflète ces exécutions.
Mo Qatanani, Chief Scientific Officer von Scholar Rock Holding Corp (SRRK), meldete einen Insider-Verkauf mit einem Formular Form 4. Am 22.09.2025 verkaufte die meldende Person 3.353 Aktien der Stammaktien von Scholar Rock zu einem gewichteten Durchschnittspreis von $30.6729 im Rahmen eines Rule 10b5-1 Handelsplans, der am 31. März 2025 beschlossen wurde. Nach dem Verkauf hält die meldende Person vorteilhaft 108.964 Aktien, vertreten durch RSU. Das Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet und am 24.09.2025 eingereicht. Die Einreichung offenbart, dass der Verkauf in mehreren Transaktionen zu Preisen von $30.33 bis $30.85 erfolgte, und der gewichtete Durchschnitt spiegelt diese Ausführungen wider.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Qatanani Mo

(Last) (First) (Middle)
301 BINNEY STREET

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Scholar Rock Holding Corp [ SRRK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF SCIENTIFIC OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/22/2025 S 3,353(1) D $30.6729(2) 108,964(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.33 to $30.85, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
3. Consists of 108,964 RSUs.
/s/ Junlin Ho, Attorney-in-Fact for Mo Qatanani 09/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SRRK Chief Scientific Officer report on Form 4?

The CSO, Mo Qatanani, reported selling 3,353 shares of Scholar Rock common stock on 09/22/2025 under a Rule 10b5-1 plan.

At what price were the SRRK shares sold in the Form 4 filing?

The shares were sold at a weighted average price of $30.6729, with individual executions ranging from $30.33 to $30.85.

How many SRRK shares does the reporting person beneficially own after the transaction?

The filing states the reporting person beneficially owns 108,964 shares, consisting of RSUs.

Was the sale part of a pre-established trading plan for SRRK insider trades?

Yes. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.

Who signed the Form 4 filing for the SRRK insider transaction?

The Form 4 was signed by Junlin Ho, Attorney-in-Fact, on behalf of Mo Qatanani and dated 09/24/2025.
Scholar Rock Holding

NASDAQ:SRRK

SRRK Rankings

SRRK Latest News

SRRK Latest SEC Filings

SRRK Stock Data

3.24B
91.67M
4.3%
120.43%
17.51%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE